Serum estradiol and danazol. I. Endometriosis response, side effects, administration interval, concurrent spironolactone and dexamethasone
Other
OA: closed
CC0
⤵ 14 in-corpus citations
AI-generated summary
This study investigated the effects of serum estradiol and danazol on endometriosis response, side effects, administration interval, and concurrent use of spironolactone and dexamethasone.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Serum estradiol (E2) levels and resolution of endometriosis were evaluated in 42 women after 75 days of danazol treatment. Complete or almost complete remission occurred when radioimmunoassay E2 levels were less than 15 pg/ml in extensive, less than 22 pg/ml in severe, and less than 41 pg/ml in moderate endometriosis. E2 less than or equal to 20 pg/ml occurred in 23% of 104 patients given 400 mg every 12 hours but in none weighing over 150 pounds (68 kg). E2 greater than 100 pg/ml occurred in 7%. The mean E2 levels were identical with 400 mg every 12 hours and 200 mg every 8 hours. The E2 level was 40% lower with 200 mg every 6 hours than with 400 mg every 12 hours (P less than 0.001). Dexamethasone further decreased E2 levels by 61% (P less than 0.001). Spironolactone decreased androgen symptoms but increased E2 levels by 49% (P less than 0.01).
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (25)
- A comparison of plasma protein changes induced by danazol, pregnancy, and estrogens via openalex
- Changes of prolactin secretion following long-term danazol application via openalex
- Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity via openalex
- Danazol: endocrine and endometrial effects via openalex
- Danazol: endocrine consequences in healthy women via openalex
- Danazol has progestin-like actions on the human endometrium via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Effect of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization via openalex
- Effects of danazol in the treatment of severe endometriosis via openalex
- Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women via openalex
- Hormonal changes associated with Danazol therapy via openalex
- Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis via openalex
- Metabolic effects of danazol. via openalex
- Selective inhibition by danazol of follicle stimulating hormone during the luteal phase via openalex
- Sex steroid levels during treatment of endometriosis via openalex
- The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers via openalex
- The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women via openalex
- W2313274945 via openalex
- W2210149071 via openalex
- W2113738015 via openalex
- W2009498181 via openalex
- W4285719527 via openalex
- W6601400068 via openalex
- W2410955081 via openalex
- W6793613985 via openalex
Cited by (14)
- Danazol 2022
- Vaginally Administered Danazol: An Overlooked Option in the Treatment of Rectovaginal Endometriosis? 2015
- Progestins for the Treatment of Endometriosis: An Update: 2010
- Progestins for the Treatment of Endometriosis: An Update 2010
- Endometriosis: an overview of the disease and its treatment 2000
- Correlation of fecundability and serum estradiol after danazol treatment in patients with advanced endometriosis 1996
- Plasma protein changes induced by two orally administered androgen derivatives 1996
- Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository 1995
- Tissue factors influencing growth and maintenance of endometriosis 1991
- Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin 1989
- Genital bleeding during the administration of danazol 1988
- Endometriosis of the urinary tract 1988
- Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol 1988
- Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients 1986
SciLite annotations
chemicals 9
estradiol
danazol
spironolactone
dexamethasone
estradiol
danazol
dexamethasone
spironolactone
androgen
Source provenance
- europepmc
- last seen: 2026-10-26T06:15:05.866214+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:58:15.129929+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK